Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo

PURPOSE: Oncolytic virus therapy has gradually become an integral approach in cancer treatment. We explored the therapeutic effects of the combination of a dual cancer-selective anti-tumor recombinant adenovirus (Ad-Apoptin-hTERTp-E1a) and cyclophosphamide on breast cancer cells. METHODS: The inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Zuo, Shuting, Zhang, Yan, Li, Shanzhi, Shi, Ying, Du, Tonghua, Han, Jicheng, Jin, Ningyi, Li, Yiquan, Li, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484773/
https://www.ncbi.nlm.nih.gov/pubmed/36133740
http://dx.doi.org/10.2147/CMAR.S373271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484773/
https://www.ncbi.nlm.nih.gov/pubmed/36133740
http://dx.doi.org/10.2147/CMAR.S373271

Ejemplares similares